Viemed Healthcare Management
Management criteria checks 3/4
Viemed Healthcare's CEO is Casey Hoyt, appointed in Dec 2017, has a tenure of 7.75 years. total yearly compensation is $2.62M, comprised of 20.2% salary and 79.8% bonuses, including company stock and options. directly owns 5.79% of the company’s shares, worth $15.07M. The average tenure of the management team and the board of directors is 7.8 years and 7.8 years respectively.
Key information
Casey Hoyt
Chief executive officer
US$2.6m
Total compensation
| CEO salary percentage | 20.23% |
| CEO tenure | 7.8yrs |
| CEO ownership | 5.8% |
| Management average tenure | 7.8yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
Revamped Sales Strategy And Legislative Advances Set To Propel Healthcare Innovator To New Heights
Accelerated recruiting and a refined sales force focusing on ventilator growth are set to boost revenue through an increase in ventilator setups.When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?
Apr 11
These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely
Mar 07Viemed Healthcare: Comments On Q2 Earnings
Aug 25Viemed Healthcare Q2 2022 Earnings Preview
Aug 02Viemed Healthcare: New Bullish Trend Has Just Begun
Dec 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | US$14m |
| Mar 31 2025 | n/a | n/a | US$12m |
| Dec 31 2024 | US$3m | US$530k | US$11m |
| Sep 30 2024 | n/a | n/a | US$10m |
| Jun 30 2024 | n/a | n/a | US$9m |
| Mar 31 2024 | n/a | n/a | US$10m |
| Dec 31 2023 | US$3m | US$509k | US$10m |
| Sep 30 2023 | n/a | n/a | US$9m |
| Jun 30 2023 | n/a | n/a | US$7m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$2m | US$470k | US$6m |
| Sep 30 2022 | n/a | n/a | US$8m |
| Jun 30 2022 | n/a | n/a | US$9m |
| Mar 31 2022 | n/a | n/a | US$9m |
| Dec 31 2021 | US$2m | US$470k | US$9m |
| Sep 30 2021 | n/a | n/a | US$10m |
| Jun 30 2021 | n/a | n/a | US$11m |
| Mar 31 2021 | n/a | n/a | US$29m |
| Dec 31 2020 | US$2m | US$441k | US$32m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$29m |
| Mar 31 2020 | n/a | n/a | US$11m |
| Dec 31 2019 | US$2m | US$425k | US$9m |
| Sep 30 2019 | n/a | n/a | US$9m |
| Jun 30 2019 | n/a | n/a | US$8m |
| Mar 31 2019 | n/a | n/a | US$9m |
| Dec 31 2018 | US$2m | US$389k | US$10m |
Compensation vs Market: Casey's total compensation ($USD2.62M) is above average for companies of similar size in the US market ($USD1.54M).
Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.
CEO
Casey Hoyt (48 yo)
Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and Chief Executive Officer since December 2017. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Co...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 7.8yrs | US$2.62m | 5.79% $ 15.1m | |
| President | 7.8yrs | US$2.01m | 4.77% $ 12.4m | |
| Chief Financial Officer | 7.8yrs | US$872.18k | 0.21% $ 556.9k | |
| COO & Director | 7.8yrs | US$2.00m | 0.71% $ 1.8m | |
| General Counsel & Corporate Secretary | 3.1yrs | US$947.23k | 0.066% $ 171.1k | |
| Chief Medical Officer & Director | 7.8yrs | US$376.73k | 0.18% $ 466.0k | |
| Vice President of Sales | 7.5yrs | US$805.30k | 0.22% $ 564.9k | |
| Chief Business Development Officer | 3.1yrs | no data | no data |
Experienced Management: VMD's management team is seasoned and experienced (7.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 8.8yrs | US$2.62m | 5.79% $ 15.1m | |
| COO & Director | 7.8yrs | US$2.00m | 0.71% $ 1.8m | |
| Chief Medical Officer & Director | 7.8yrs | US$376.73k | 0.18% $ 466.0k | |
| Independent Chairman | 7.8yrs | US$251.63k | 0.32% $ 842.0k | |
| Independent Director | 7.8yrs | US$232.00k | 0.37% $ 956.7k | |
| Independent Director | 4.8yrs | US$221.00k | 0.17% $ 452.9k | |
| Independent Director | 7.8yrs | US$234.00k | 0.25% $ 640.9k |
Experienced Board: VMD's board of directors are considered experienced (7.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/09 16:49 |
| End of Day Share Price | 2025/09/09 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Viemed Healthcare, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Doug Cooper | Beacon Securities Limited |
| Vadim Merkulov | Freedom Broker |
| Ilya Zubkov | Freedom Broker |